The Importance of Social Support in Coping With the Ambiguous Loss of Rare Disease
By Craig Delarge
I regularly get calls from people who find themselves faced suddenly with the challenge of living with or caring for an ill loved one. One of the first pieces of advice I always offer is to seek out and become a part of a peer-support community. Next to a focus on self-care, social support may be the most important factor in successful long-term coping with ambiguous loss (AL)—a sense of loss characterized by uncertainty about the loss of a loved one and/or the life we once knew.
For me, through nearly two decades of caring for an ill loved one, social support has been essential in building my confidence and ability to handle the challenges of AL. Peer-support groups of others who are undergoing similar experiences helped normalize otherwise abnormal situations in which my typical social supports of family, friends, church, and work were not enough. This normalization of the generally abnormal has made all the difference to me in surviving—and at times even thriving—in the face of AL.
Social support can take many different forms. It may be formal, involving therapists, coaches, physicians and other health care providers, and social- and human-services professionals. Less formal support, such as online or in-person peer-support groups—can also be very valuable. As you engage and connect more deeply with your support community, you will become educated, access resources you may not have known about, and derive emotional, spiritual, and psychological support. Over time, you will become a source of education, connection, and support for others.
How does social support impact the quality of life for people facing AL due to a rare disease? A study by Kerrilynn Hall, a PhD student at North Central University, examined the psychosocial impact of sarcoidosis, a rare disease for which there is no known cause. For the study, Hall interviewed 12 people with sarcoidosis about their experiences. The study concluded that the effect of AL on quality of life varies based on a number of factors, including illness severity, the strength of a person’s social support, trust in the health care system, and financial burden. Hall found that many of the people she interviewed for her study felt their families did not understand what they were going through. Loved ones’ misperceptions about the disease can make it even more difficult for patients to cope with illness. Finding social support outside the home may be especially important for people in situations like this.
Though we cannot undo our loss, we can grow with it. Social support is but one element of successfully dealing with AL. To help you build your resilience and ability to cope in the face of AL, I recommend that you:
Seek social support via “connected communities” of professionals and peers
Develop ease with imperfection through an acceptance of loss and ambiguity
Master (skillfully manage) the elements of your situation that can be controlled
Employ the techniques of mindfulness (nonjudgmentally paying attention) and storytelling (sharing common experiences to make meaning)
My hope is that you and your beloved community will be well and resilient as you learn to cope with your own AL.
Rare Disease Organizations:
National Organization for Rare Disorders: https://rarediseases.org/
Rare Advocacy Movement: https://www.rareadvocacymovement.com/
Global Genes: https://globalgenes.org/
About the Author
Craig A. DeLarge is a digital health strategist, mental health advocate, educator, and leadership professor and coach. He works to improve health and develop leaders, these days, at WiseWorking Leadership Coaching, LLC, The Digital Mental Health Project, and Temple University. He lives in Philadelphia.
Latest From Know Rare
A Danon disease study, led by researcher Dr. Barry Greenberg and published in the New England Journal of Medicine, wins an award! The study focuses on gene therapy as a potential treatment option for Danon disease. The study showed early signs that gene therapy may help the hearts of people with Danon disease.
A poster, presented at the European Hematology Association meeting in June, described a study that looked at tiredness (fatigue) in adults with immune thrombocytopenia (ITP). Researchers wanted to see if fatigue was related to bleeding or other health test results.
Lucky Shanmugan was recently featured in Porter Ranch Living, his local magazine, for Father’s Day: in his interview, Lucky talks about Osteogenesis Imperfecta, a rare genetic or heritable disorder of the connective tissue, and the incredible journey towards his official diagnosis.
Here are 9 things Chris Anselmo wishes someone had told him after his rare disease diagnosis.
A family’s hardships and resilience in finding answers and getting a diagnosis for their child, after numerous tests, brain biopsies, and hospitalizations. And the relief but also grief in finally putting a name to the rare disease that affects their child: BCL11B-related disorder.
The Danon Foundation boldly empowers people living with Danon disease, providing trusted information, resources and support to help navigate life, from diagnosis to treatment.
For many families, caregiving for a child with a rare or medically complex condition is a full-time job. The problem is, it’s a job with no training, no time off, and no clear job description. If you’re looking for the light at the end of the tunnel, you don’t have to search alone. Check out some of Paige’s favorite resources.
For most of celiacs, despite months on a strict GF diet, energy stays low and blood work reveals nutrient deficiencies. The lesson? A "gluten-free" label isn't a health guarantee—just a guarantee you'll pay more.
If you’ve been told you have seronegative NMOSD, there’s nearly 50/50 chance you have a different antibody causing your symptoms –MOG antibody.
Therapy Near Me is a nationwide mental health service based in Australia, providing easy access to psychologists, counsellors, behaviour support practitioners and social workers.
At the annual Kidney Week of the American Society of Nephrologists (ASN), the world’s largest kidney healthcare professional organization, new advances in research were highlighted. Over $35 million has been invested in research with the ASN, and there are many treatments in development for IgA Nephropathy (IgAN), with researchers actively investigating more than 20 different drugs.
When I was diagnosed with celiac disease, I thought avoiding bread and pasta would be enough. I quickly learned that living truly gluten-free is far more complex, and I'm sharing my experience to help newly diagnosed individuals understand what lies ahead.
Retinopathy is an eye problem that many people with Danon disease have. It can cause dark spots in the outer part of the eye, blurry or worse vision, and unusual test results on an eye exam. Sometimes these eye changes show up before heart problems, so an eye check can help find the disease early.
A heartfelt story about a mother who found purpose and strength among the tragedy of losing a child diagnosed with an ultra rare genetic disorder.
Kaya Girl Legacy, Inc. is a Florida-based nonprofit founded in memory of Kaya Humbert, a beautiful baby girl born with Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), one of 46 known cases worldwide. The foundation is dedicated to empowering families with knowledge about their genetic health and advocating for early access to genetic testing and rare disease awareness.
A prose poem by Jim Kuhn, a rare warrior living with Sarcoidosis, a rare inflammatory disease.
Rare Mom Laura shares how her family’s prep for Halloween turned into a burst of familial love and creativity, as they all worked together in designing and building a costume for Alden, her medically complex son.
Instead of starting with a newly discovered drug compound, PCOR is a type of research that starts by turning to patients and caregivers and asking, What matters most to you? What questions do we want answered? What symptoms do we wish were better managed? What keeps us up at night?
Four years ago, Michael Grivas’ life suddenly changed when he learned that he had Brugada Syndrome, a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. Learn more about his story.
Fatigue is a very common and often debilitating symptom of IgAN. It is linked to disease progression and reduced kidney function, but other factors like inflammation, anemia, and mental health also play a role. In a 2025 study, the majority of patients with IgAN reported fatigue, and patients with more severe proteinuria and lower kidney filtration rates (eGFR) experienced worse fatigue.
Why is it so hard to accept help? Humans often associate help with weakness and loss of independence and control. However, if we reframe our thoughts, accepting help can be viewed as a form of empowerment: showing vulnerability and trusting someone to help us requires great strength.
There is so much mental load with having a rare disease. Rare Human Lindsay shares there are things she does not care about anymore, as she manages rare disease symptoms, specialists, and clinical trials.
Rare Human Lindsay shares her "silver linings." It's not 'what doesn't kill you makes you stronger,' instead it's what doesn't kill you makes you braver. She shares that she has found deeper connections with others, improved her ability to ask for and accept help, and not been as afraid of the word "no."
Journalist and rare disease advocate Lindsay Guentzel breaks down why clinical trials are a lifeline for the rare disease community. With only 5% of known rare diseases having an FDA-approved therapy, trials often represent the only path toward treatment, progress, and hope.
Lindsay was diagnosed with dermatomyositis a couple of years ago. Since then, she has undergone more than 350 doctor appointments, 250+ hours of infusions, 10+ ER visits, while juggling insurance approvals, rides, and her pain and fatigue.
Rare Human Lindsay is in the midst of her first clinical trial for dermatomyositis, a rare inflammatory disease that primarily affects the skin and muscles. So far, she has learned so much about the process and is eager to share some of her insights with the rare disease community.
While in a clinical study, Lindsay talks about how hard it is not to have a community to turn to, especially when there are only a few patients with her rare disease (dermatomyositis) who have experienced the same treatment she just went through.
Craig Delarge
Craig A. DeLarge is a digital health strategist, mental health advocate and educator, and leadership professor and coach. He works to improve health and develop leaders, these days, at WiseWorking Leadership Coaching, LLC, The Digital Mental Health Project, and Temple University. He lives in Philadelphia.